The synthetic hormone,
diethylstilbestrol (DES) was withdrawn in the 1970s when it was found to be associated with vaginal cancer and fertility disorders among the women who took it.
High-dose intravenous
diethylstilbestrol has been successfull in treating disseminated intravascular coagulation of acute onset in several patients with widespread cancer of the prostate.(5) In this case report it is interesting to note that the patient's bleeding stopped after standard oral doses of
diethylstilbestrol.
Do not increase the screening interval beyond annual testing for women who are HIV-positive, who are immunosuppressed, who were exposed in utero to
diethylstilbestrol, or who have been treated for CIN 2 or 3 or adenocarcinoma in situ.
Data from one study of nearly 1,500 women conducted by the National Institute of Environmental Health Sciences identified prenatal
diethylstilbestrol (DES) exposure and young age at menarche as fibroid risk factors, reported Donna Day Baird, Ph.D.
Diethylstilbestrol (DES), a highly potent, orally available synthetic estrogen, is perhaps the most studied among the class of exogenous estrogens since being strongly associated with vaginal adenocarcinoma and abnormalities of the uterus and cervix in young women who were exposed via pharmacological use by their mothers during pregnancy (Herbst et al.
He first became interested in livestock hormones in the early 1970s, when he learned that farmers were giving the synthetic hormone
diethylstilbestrol (DES) to chickens and cattle.
In utero exposure to
diethylstilbestrol (DES), maternal prepregnancy or gestational diabetes, and having been born from a monozygotic multiple birth were most strongly associated with early-onset fibroids.
Washington, May 29 (ANI): Exposure in the womb to chemicals like Bisphenol-A (BPA) and
Diethylstilbestrol (DES) can increase an offspring's risk of breast cancer, according to a new study.
Medical research indicates that daughters of women who took the drug
diethylstilbestrol (DES), during the years 1938 through 1971 to prevent miscarriage, have an increased risk of developing this disease.
The type of estrogen treatment was unknown for 25 women, but in all other cases the treated women had been prescribed
diethylstilbestrol (DES) or ethinyl estradiol; DES was in use before 1971.
Screen more frequently those who are HIV-positive, are immunosuppressed, are cervical cancer survivors, or were exposed to
diethylstilbestrol in utero.
Other mice received comparable doses of
diethylstilbestrol (DES), a synthetic estrogen known to cause cancer.
